During the past decade, Capital Health District Authority, Department of Medicine, Division of Nephrology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Health District Authority, Department of Medicine, Division of Nephrology" #1 collaborator was "Capital Health, Canada" with 1 trials as a collaborator, "Dalhousie University" with 1 trials as a collaborator and "Université de Montréal" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Capital Health District Authority, Department of Medicine, Division of Nephrology" are "Blood Coagulation Disorders" (1 trials) and "Chronic Renal Insufficiency" (1 trials). Many other conditions were trialed in "Capital Health District Authority, Department of Medicine, Division of Nephrology" in a lesser frequency.

Most popular intervention types in "Capital Health District Authority, Department of Medicine, Division of Nephrology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alteplase" (1 trials) and "Dabigatran Etexilate 110 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Capital Health District Authority, Department of Medicine, Division of Nephrology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Capital Health District Authority, Department of Medicine, Division of Nephrology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Capital Health District Authority, Department of Medicine, Division of Nephrology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Capital Health District Authority, Department of Medicine, Division of Nephrology, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".